Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics

被引：6
|
作者：
Wang, Yunxia [1 ]
Liu, Xiaolin [1 ]
Gong, Luyao [1 ]
Ding, Weihong [2 ]
Hao, Wenjing [1 ]
Peng, Yeheng [1 ]
Zhang, Jun [1 ]
Cai, Weimin [1 ]
Gao, Yuan [1 ]
机构：
[1] Fudan Univ, Sch Pharm, Shanghai, Peoples R China
[2] Fudan Univ, Huashan Hosp, Dept Urol, Shanghai, Peoples R China
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷 / 23期
基金：
中国国家自然科学基金;
关键词：
biomarkers; drug resistance; renal cell carcinoma; sunitinib; treatment strategies; CONCISE GUIDE; MULTIDRUG-RESISTANCE; KINASE INHIBITORS; TUMOR PROGRESSION; EXPRESSION; PROTEIN; CANCER; POLYMORPHISMS; EFFICACY; THERAPY;
D O I：
10.1111/bph.16252
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Sunitinib is the first-line drug for renal cell carcinoma (RCC) treatment. However, patients who received sunitinib treatment will ultimately develop drug resistance after 6-15 months, creating a huge obstacle to the current treatment of renal cell carcinoma. Therefore, it is urgent to clarify the mechanisms of sunitinib resistance and develop new strategies to overcome it. In this review, the mechanisms of sunitinib resistance in renal cell carcinoma have been summarized based on five topics: activation of bypass or alternative pathway, inadequate drug accumulation, tumour microenvironment, metabolic reprogramming and epigenetic regulation. Furthermore, present and potential biomarkers, as well as potential treatment strategies for overcoming sunitinib resistance in renal cell carcinoma, are also covered.
引用
收藏
页码：2937 / 2955
页数：19
相关论文
共 50 条
  • [1] Sunitinib resistance in renal cell carcinoma
    Morais, Christudas
    JOURNAL OF KIDNEY CANCER AND VHL, 2014, 1 (01): : 1 - 11
  • [2] Metabolomic Analysis to Elucidate Mechanisms of Sunitinib Resistance in Renal Cell Carcinoma
    Sato, Tomonori
    Kawasaki, Yoshihide
    Maekawa, Masamitsu
    Takasaki, Shinya
    Morozumi, Kento
    Sato, Masahiko
    Shimada, Shuichi
    Kawamorita, Naoki
    Yamashita, Shinichi
    Mitsuzuka, Koji
    Mano, Nariyasu
    Ito, Akihiro
    METABOLITES, 2021, 11 (01) : 1 - 16
  • [3] Metabolomic approach to elucidate mechanisms of acquired resistance to sunitinib in renal cell carcinoma
    Sato, Tomonori
    Kawasaki, Yoshihide
    Maekawa, Masamitsu
    Takasaki, Shinya
    Sato, Masahiko
    Shimada, Shuichi
    Ito, Akihiro
    CANCER SCIENCE, 2021, 112 : 833 - 833
  • [4] Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers
    Jin, Juan
    Xie, Yuhao
    Zhang, Jin-Shi
    Wang, Jing-Quan
    Dai, Shi-Jie
    He, Wen-fang
    Li, Shou-Ye
    Ashby Jr, Charles R.
    Chen, Zhe-Sheng
    He, Qiang
    DRUG RESISTANCE UPDATES, 2023, 67
  • [5] METABOLOMIC APPROACH TO ELUCIDATE MECHANISMS OF ACQUIRED RESISTANCE TO SUNITINIB IN RENAL CELL CARCINOMA
    Sato, Tomonori
    Kawasaki, Yoshihide
    Maekawa, Masamitsu
    Takasaki, Shinya
    Morozumi, Kento
    Sato, Masahiko
    Shimada, Shuichi
    Kawamorita, Naoki
    Yamashita, Shinichi
    Mitsuzuka, Koji
    Ito, Akihiro
    JOURNAL OF UROLOGY, 2020, 203 : E111 - E111
  • [6] Androgen receptor expression is associated with sunitinib resistance in renal cell carcinoma models
    Adelaiye-Ogala, Remi M.
    Chintala, Sreenivasulu
    Orillion, Ashley
    Pettazzoni, Piergiorgio
    Elbanna, May
    Elzey, Bennett
    Miles, Kiersten Marie
    Kao, Chinghai
    Draetta, Giulio F.
    Pili, Roberto
    CANCER RESEARCH, 2016, 76
  • [7] Epigenetic changes associated with resistance to sunitinib in human clear cell renal cell carcinoma models
    Adelaiye, Remi
    Miles, Kiersten Marie
    Ciamporcero, Eric
    Conroy, Dylan
    Ramakrishnan, Swathi
    Orillion, Ashley
    Ku, Sheng Y.
    Elbanna, May
    Shen, Li
    Chintala, Sreenivasulu
    Pili, Roberto
    CANCER RESEARCH, 2014, 74 (19)
  • [8] Resistance to sunitinib in renal cell carcinoma: From molecular mechanisms to predictive markers and future perspectives
    Joosten, S. C.
    Hamming, L.
    Soetekouw, P. M.
    Aarts, M. J.
    Veeck, J.
    van Engeland, M.
    Tjan-Heijnen, V. C.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2015, 1855 (01): : 1 - 16
  • [9] The intersection of sunitinib with the immunosuppressive microenvironment of renal cell carcinoma: implications for future therapeutics
    Salas, Renee N.
    Finke, James H.
    Rini, Brian I.
    TARGETED ONCOLOGY, 2007, 2 (04) : 225 - 234
  • [10] The intersection of sunitinib with the immunosuppressive microenvironment of renal cell carcinoma: implications for future therapeutics
    Renee N. Salas
    James H. Finke
    Brian I. Rini
    Targeted Oncology, 2007, 2 : 225 - 234
12345